All In MedTech

FDA Clearance Tracker · P160030-S027

Freestyle Libre Pro

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 21, 2018 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 21, 2018

Approved

Time to decision

85 days

Received Sep 27, 2018. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P160030-S027
Device name
Freestyle Libre Pro
Applicant location
Alameda, CA
Received
Sep 27, 2018
Decided
Dec 21, 2018
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Change Design/Components/Specifications/Material
Original approval
P160030

Device type

Device class
Class III

Every decision under product code PZE

FDA's approval statement

As written in FDA's record.

Approval for modification of the membrane layer formulation of the FreeStyle Libre and FreeStyle Libre Pro sensor components and an addition of a shipping method for shipment of sensor components.

Source documents

Other decisions for Abbott Diabetes Care, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

7 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.